The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Malignant glioma: genetics and biology of a grave matter
Open accessAbstract
Malignant brain tumors strike deep into the psyche of those receiving and those delivering the diagnosis. Malignant gliomas, the most common subtype of primary brain tumors, are aggressive, highly invasive, and neurologically destructive tumors considered to be among the deadliest of human cancers. In its most aggressive manifestation, glioblastoma (GBM), median survival ranges from 9 to 12 months, despite maximum treatment efforts—a statistical fact that has changed little over several decades of technological advances in neurosurgery, radiation therapy, and clinical trials of conventional and novel therapeutics. Over the same time period, there has been an explosion of knowledge in cancer biology and basic science discovery that has fueled meaningful progress in the treatment of many common human cancers, including those of the breast, lung, and prostate. It is perplexing that therapies used effectively in the treatment of these solid tumors are overwhelmingly ineffective in the treatment of GBM, perhaps reflecting the eccentric biology and cellular origin of this neoplasm. To date, only one new agent has been documented to have modest activity against intermediate-grade gliomas, whereas no effective agents have emerged for the treatment of GBM, despite 20 years of enrolling patients in clinical trials. It is ironic that although a comprehensive view of the genetic lesions encountered in malignant gliomas has been compiled, substantive conceptual and practical barriers remain in assigning functional significance to these genetic changes and in harnessing this basic information into the development of drugs that make a difference in patient care. The history of treating malignant gliomas dates back to the middle of the 19th century and parallels landmark advances in modern surgical technique and the clinical discipline of neurology. The first brain tumor surgery of the modern era was performed in 1884 by Rickman
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“MDM2 inhibits p53 transcriptional activity directly by binding to the N-terminal transactivation domain and also functions as an E3 ubiquitin ligase, serving a critical role in the ubiquitination and proteosomal degradation of p53 (Momand et al. 1992; Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Mode of cell migration to the superficial layers of fetal monkey neocortex
Rakic, P. (1972) · Journal of Comparative Neurology · doi:10.1002/cne.901450105 · Cited by 2,170
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
Johansson, C. B., Momma, S., Clarke, D. L., Risling, M., Lendahl, U., & Frisén, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80956-3 · Cited by 1,875
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Self-citationRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Self-citationPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., & Schlessinger, J. (1985) · Nature · doi:10.1038/313144a0 · Cited by 1,503
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Turning Brain into Blood: A Hematopoietic Fate Adopted by Adult Neural Stem Cells in Vivo
Bjornson, C. R. R., Rietze, R. L., Reynolds, B. A., Magli, M. C., & Vescovi, A. L. (1999) · Science · doi:10.1126/science.283.5401.534 · Cited by 1,414
Reynolds, B. A., & Weiss, S. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0090 · Cited by 1,360
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Control of Neuronal Precursor Proliferation in the Cerebellum by Sonic Hedgehog
Wechsler-Reya, R. J., & Scott, M. P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80682-0 · Cited by 1,341
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Biology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,220
Induction of neurogenesis in the neocortex of adult mice
Magavi, S. S., Leavitt, B. R., & Macklis, J. D. (2000) · Nature · doi:10.1038/35016083 · Cited by 1,216
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12846 · Cited by 1,207
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
The Adult Rat Hippocampus Contains Primordial Neural Stem Cells
Palmer, T. D., Takahashi, J., & Gage, F. H. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0595 · Cited by 1,090
Breier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Generalized Potential of Adult Neural Stem Cells
Clarke, D. L., Johansson, C. B., Wilbertz, J., Veress, B., Nilsson, E., Karlström, H., Lendahl, U., & Frisén, J. (2000) · Science · doi:10.1126/science.288.5471.1660 · Cited by 1,062
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
Miettinen, P. J., Berger, J. E., Meneses, J., Phung, Y., Pedersen, R. A., Werb, Z., & Derynck, R. (1995) · Nature · doi:10.1038/376337a0 · Cited by 1,039
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Self-citationTumors of the Brain and Nervous System after Radiotherapy in Childhood
Ron, E., Modan, B., Boice, J. D., Alfandary, E., Stovall, M., Chetrit, A., & Katz, L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191601 · Cited by 934
Sonic hedgehog regulates the growth and patterning of the cerebellum
Dahmane, N., & Altaba, A. R. I. (1999) · Development · doi:10.1242/dev.126.14.3089 · Cited by 907
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000) · Nature Genetics · doi:10.1038/75596 · Cited by 905
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
CENTRAL NERVOUS SYSTEM NEURONAL MIGRATION
Hatten, M. E. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.511 · Cited by 797
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Craig, C., Tropepe, V, Morshead, C., Reynolds, B., Weiss, S., & van der Kooy, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02649.1996 · Cited by 752
Hermanson, M., Funa, N. S., Hartman, M., Claesson, L., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 705
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, L., Demunck, H., Kasper, M., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
Luetteke, N. C., Qiu, T. H., Peiffer, R. L., Oliver, P., Smithies, O., & Lee, D. C. (1993) · Cell · doi:10.1016/0092-8674(93)90228-i · Cited by 659
Wallace, V. A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80195-x · Cited by 648
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 630
Self-citationYarden, Y., & Schlessinger, J. (1987) · Biochemistry · doi:10.1021/bi00379a035 · Cited by 627
FGF modulates the PDGF-driven pathway of oligodendrocyte development
McKinnon, R. D., Matsui, T., Dubois-Dalcq, M., & Aaronsont, S. A. (1990) · Neuron · doi:10.1016/0896-6273(90)90215-2 · Cited by 597
Sporadic medulloblastomas contain PTCH mutations.
Raffel, C., Jenkins, R. B., Frederick, L. A., Hebrink, D. M., Alderete, B. E., Fults, D. W., & James, C. D. (1997) · PubMed · Cited by 570
Platelet-derived growth factor receptor signals.
Claesson-Welsh, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31591-6 · Cited by 561
Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 560
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Self-citationVoigt, T. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902890106 · Cited by 549
Second Neoplasms after Acute Lymphoblastic Leukemia in Childhood
Neglia, J. P., Meadows, A. T., Robison, L. L., Kim, T. H., Newton, W. A., Ruymann, F. B., Sather, H. N., & Hammond, G. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251902 · Cited by 549
Goldman, C. K., Kim, J., Wong, W. L., King, V, Brock, T., & Gillespie, G. Y. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.1.121 · Cited by 531
(1997) · PubMed · Cited by 512
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Self-citationOligodendrocyte Population Dynamics and the Role of PDGF In Vivo
Calver, A. R., Hall, A. C., Yu, W.-P., Walsh, F. S., Heath, J. K., Betsholtz, C., & Richardson, W. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80469-9 · Cited by 501
Li, D.-M., & Sun, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15406 · Cited by 489
Platelet-derived growth factor: mechanism of action and possible in vivo function.
Heldin, C. H., & Westermark, B. (1990) · Cell Regulation · doi:10.1091/mbc.1.8.555 · Cited by 486
Skeletal myogenic potential of human and mouse neural stem cells
Galli, R., Borello, U., Gritti, A., Minasi, M. G., Bjornson, C., Coletta, M., Mora, M., De Angelis, M. G. C., Fiocco, R., Cossu, G., et al. (2000) · Nature Neuroscience · doi:10.1038/79924 · Cited by 483
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng, D., Hu, R. H., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., et al. (1997) · PubMed · Cited by 463
Shapiro, W. R., Green, S. B., Burger, P. C., Mahaley, M. S., Selker, R. G., VanGilder, J. C., Robertson, J. T., Ransohoff, J., Mealey, J., Strike, T. A., et al. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.1.0001 · Cited by 458
Hatten, M. E. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90044-b · Cited by 448
Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A., & Poustka, A. (1997) · Nature Genetics · doi:10.1038/ng0997-32 · Cited by 448
Pringle, N. P., Mudhar, H. S., Collarini, E. J., & Richardson, W. D. (1992) · Development · doi:10.1242/dev.115.2.535 · Cited by 443
The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.
Luetteke, N. C., Phillips, H. K., Qiu, T. H., Copeland, N. G., Earp, H. S., Jenkins, N. A., & Lee, D. C. (1994) · Genes & Development · doi:10.1101/gad.8.4.399 · Cited by 441
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Schmidt, E., Ichimura, K., Reifenberger, G., & Collins, V. P. (1994) · PubMed · Cited by 436
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
Furnari, F. B., Lin, H., Huang, H.-J. S., & Cavenee, W. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12479 · Cited by 434
Self-citationIno, Y., Betensky, R. A., Ƶlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Ramsay, D. A., Cairncross, J. G., & Louis, D. N. (2001) · PubMed · Cited by 432
Self-citationNf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E., & Jacks, T. (2000) · Nature Genetics · doi:10.1038/79075 · Cited by 425
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas
Fine, H. A., Figg, W. D., Jaeckle, K., Wen, P. Y., Kyritsis, A. P., Loeffler, J. S., Levin, V. A., Black, P. M., Kaplan, R., Pluda, J. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.708 · Cited by 423
THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE
SCHERER, H. J. (1940) · Brain · doi:10.1093/brain/63.1.1 · Cited by 408
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
Self-citationCDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Self-citationFurnari, F. B., Huang, H., & Cavenee, W. K. (1998) · PubMed · Cited by 395
Self-citationHumphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., & Bigner, D. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4207 · Cited by 382
PDGF A-chain gene is expressed by mammalian neurons during development and in maturity
Yeh, H.-J., Ruit, K. G., Wang, Y.-X., Parks, W. C., Snider, W. D., & Deuel, T. F. (1991) · Cell · doi:10.1016/0092-8674(91)90222-k · Cited by 364
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W. K., & Huang, H.-J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5724 · Cited by 363
Self-citationKRAUS, J. A., KOOPMANN, J., KASKEL, P., MAINTZ, D., BRANDNER, S., SCHRAMM, J., LOUIS, D. N., WIESTLER, O. D., & VON DEIMLING, A. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00011 · Cited by 349
Self-citationStem cell repopulation efficiency but not pool size is governed by p27kip1
Cheng, T., Rodrigues, N., Dombkowski, D., Stier, S., & Scadden, D. T. (2000) · Nature Medicine · doi:10.1038/81335 · Cited by 347
Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., & Cavenee, W. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8502 · Cited by 342
Self-citation(1999) · PubMed · Cited by 338
Proliferation of human malignant astrocytomas is dependent on Ras activation
Guha, A., Feldkamp, M. M., Lau, N., Boss, G., & Pawson, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201455 · Cited by 337
Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis
von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., & Louis, D. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00721.x · Cited by 331
Self-citationCharacterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., & Bigner, D. D. (1990) · PubMed · Cited by 331
Barak, Y., Gottlieb, E., Juven-Gershon, T., & Oren, M. (1994) · Genes & Development · doi:10.1101/gad.8.15.1739 · Cited by 328
Burrows, R. C., Wancio, D., Levitt, P., & Lillien, L. (1997) · Neuron · doi:10.1016/s0896-6273(00)80937-x · Cited by 325
A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
Sibilia, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.719 · Cited by 325
The p53 Gene and Protein in Human Brain Tumors
Louis, D. N. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199401000-00002 · Cited by 300
Self-citationLang, F. F., Miller, D. C., Koslow, M., & Newcomb, E. W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.81.3.0427 · Cited by 300
Zagzag, D., Amirnovin, R., Greco, M. A., Yee, H., Holash, J., Wiegand, S. J., Zabski, S., Yancopoulos, G. D., & Grumet, M. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780088 · Cited by 292
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 291
Self-citationLevison, S. W., Chuang, C., Abramson, B. J., & Goldman, J. E. (1993) · Development · doi:10.1242/dev.119.3.611 · Cited by 282
A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family
Randerson-Moor, J. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.55 · Cited by 281
Reifenberger, G., REIFENBERGER, J., Ichimura, K., Meltzer, P. S., & Collins, V. P. (1994) · PubMed · Cited by 279
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., & Oren, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2584 · Cited by 276
Gates, M. A., Thomas, L. B., Howard, E. M., Laywell, E. D., Sajin, B., Faissner, A., Götz, B., Silver, J., & Steindler, D. A. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903610205 · Cited by 268
Fidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08778.1999 · Cited by 261
(1999) · PubMed · Cited by 258
Roy, N. S., Wang, S., Harrison-Restelli, C., Benraiss, A., Fraser, R. A. R., Gravel, M., Braun, P. E., & Goldman, S. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09986.1999 · Cited by 258
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Self-citationMolecular Genetic Evidence for Subtypes of Oligoastrocytomas
MAINTZ, D., FIEDLER, K., KOOPMANN, J., ROLLBROCKER, B., NECHEV, S., LENARTZ, D., STANGL, A. P., LOUIS, D. N., SCHRAMM, J., WIESTLER, O. D., et al. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00003 · Cited by 247
Self-citation(1996) · PubMed · Cited by 242
Nakada, M., Nakamura, H., Ikeda, E., Fujimoto, N., Yamashita, J., Sato, H., Seiki, M., & Okada, Y. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65288-1 · Cited by 225
von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yaşargil, M. G., Wiestler, O. D., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0295 · Cited by 218
Self-citationCell Proliferation and Nestin Expression in the Ependyma of the Adult Rat Spinal Cord after Injury
NAMIKI, J., & TATOR, C. H. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199905000-00008 · Cited by 217
The retinoblastoma gene is involved in malignant progression of astrocytomas
Henson, J. W., Schnitker, B. L., Correa, K. M., von Deimling, A., Fassbender, F., Xu, H., Benedict, W. F., Yandell, D. W., & Louis, D. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360505 · Cited by 217
Self-citationZhang, S.-C., Ge, B., & Duncan, I. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4089 · Cited by 217
Nakagawa, T., Kubota, T., Kabuto, M., Sato, K., Kawano, H., Hayakawa, T., & Okada, Y. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.81.1.0069 · Cited by 215
Patterns and Dynamics of SVZ Cell Migration in the Postnatal Forebrain
Kakita, A., & Goldman, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80800-4 · Cited by 212
MdmX Protects p53 from Mdm2-Mediated Degradation
Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · cited 2×
“1999) as well as the ability of MDMX to regulate p53 activity in cancer cells (Jackson and Berberich 2000) should expand the search for additional genetic lesions along the p53 pathway in malignant gliomas and the way such alterations influence tumor biology and therapeutic responses.”
BackgroundDurand, B., Fero, M. L., Roberts, J. M., & Raff, M. C. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70177-0 · Cited by 208
Picksley, S. M., & Lane, D. P. (1993) · BioEssays · doi:10.1002/bies.950151008 · Cited by 207
Takagi, Y., Nozaki, K., Takahashi, J., Yodoi, J., Ishikawa, M., & Hashimoto, N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01411-0 · Cited by 201
Weber, J. D., Hu, W., Jefcoat, S. C., Raben, D. M., & Baldassare, J. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32966 · Cited by 193
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H.-W., & DePinho, R. A. (1998) · Nature · doi:10.1038/31008 · Cited by 192
Self-citationShoshan, Y., Nishiyama, A., Chang, A., Mörk, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., & Staugaitis, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10361 · Cited by 190
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J. B., Morimoto, A. M., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., et al. (1998) · PubMed · Cited by 188
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade, O. I., Jenkins, R. B., Ransom, D. T., Malik, K., Pomykala, H. M., Nobori, T., Cowan, J. M., Rowley, J. D., & Dı́az, M. O. (1992) · PubMed · Cited by 184
Ransom, D. T., Ritland, S. R., Kimmel, D. W., Moertel, C. A., Dahl, R. J., Scheithauer, B. W., Kelly, P. J., & Jenkins, R. B. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870050411 · Cited by 180
Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice
Weissenberger, J., Steinbach, J. P., Malin, G., Spada, S., Rülicke, T., & Aguzzi, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201168 · Cited by 176
A Common Neural Progenitor for the CNS and PNS
Mujtaba, T., Mayer-Proschel, M., & Rao, M. S. (1998) · Developmental Biology · doi:10.1006/dbio.1998.8913 · Cited by 174
Costello, J., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H., & Cavenee, W. K. (1997) · PubMed · Cited by 173
Self-citationp27Kip1 Regulates Cell Cycle Withdrawal of Late Multipotent Progenitor Cells in the Mammalian Retina
Levine, E. M., Close, J., Fero, M., Ostrovsky, A., & Reh, T. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9622 · Cited by 171
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm1097-1145 · Cited by 169
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays.
Huang, H., Colella, S., Kurrer, M. O., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2000) · PubMed · Cited by 169
Hunter, K. E., & Hatten, M. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2061 · Cited by 167
Allelotype of human malignant astrocytoma.
Fults, D., Pedone, C. A., Thomas, G. A., & White, R. L. (1990) · PubMed · Cited by 160
A Role for p27/Kip1 in the Control of Cerebellar Granule Cell Precursor Proliferation
Miyazawa, K., Himi, T., Garcia, V., Yamagishi, H., Sato, S., & Ishizaki, Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05756.2000 · Cited by 151
Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
Yamamoto, M., Sawaya, R. A., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 149
Ichimura, K., Schmidt, E., Miyakawa, A., Goike, H. M., & Collins, V. P. (1998) · Genes Chromosomes and Cancer · Cited by 146
Splicing into Senescence: The Curious Case of p16 and p19ARF
Haber, D. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80441-9 · Cited by 144
Soriano, E., Alvarado‐Mallart, R. M., Dumesnil, N., del Río, J. A., & Sotelo, C. (1997) · Neuron · doi:10.1016/s0896-6273(00)80298-6 · Cited by 135
Glioblastoma Cells Do Not Intravasate into Blood Vessels
Bernstein, J. J., & Woodard, C. A. (1995) · Neurosurgery · doi:10.1227/00006123-199501000-00016 · Cited by 135
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas
Chung, R. Y., Whaley, J. M., Kley, N., Anderson, K., Louis, D. N., Menon, A. G., Hettlich, C., Freiman, R. N., Hedley‐Whyte, E. T., Martuza, R. L., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030502 · Cited by 132
Self-citationLeavitt, B. R., Hernit-Grant, C. S., & Macklis, J. D. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.6982 · Cited by 128
Holland, E. C., Hively, W. P., Gallo, V., & VARMUS, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3644 · Cited by 124
Quéva, C., Hurlin, P. J., Foley, K. P., & Eisenman, R. N. (1998) · Oncogene · doi:10.1038/sj.onc.1201611 · Cited by 123
Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration
Simpson, P. B., & Armstrong, R. C. (1999) · Glia · Cited by 120
Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration
Milner, R., Anderson, H. J., Rippon, R. F., McKay, J. S., Franklin, R. J. M., Marchionni, M. A., Reynolds, R., & ffrench‐Constant, C. (1997) · Glia · Cited by 119
Loss of P16INK4 expression is frequent in high grade gliomas.
Nishikawa, R., Furnari, F. B., Lin, H., Arap, W., Berger, M. S., Cavenee, W. K., & Huang, H. (1995) · PubMed · Cited by 119
Self-citationMechanisms of Glioma Invasion: Role of Matrix-Metalloproteinases
Uhm, J. H., Dooley, N. P., Villemure, J., & Yong, V. W. (1997) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100021028 · Cited by 118
Molecular Genetic Alterations in Radiation-Induced Astrocytomas
Brat, D. J., James, C. D., Jedlicka, A., Connolly, D. C., Chang, E., Castellani, R. J., Schmid, M., Schiller, M. R., Carson, D. A., & Burger, P. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65397-7 · Cited by 112
Repression by the Mad(Mxi1)-Sin3 complex
Schreiber‐Agus, N., & DePinho, R. A. (1998) · BioEssays · Cited by 110
Self-citationNait‐Oumesmar, B., Vignais, L., & Evercooren, A. B. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00125.1997 · Cited by 110
Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme
Fults, D., & Pedone, C. A. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070311 · Cited by 107
Bullrich, F., MacLachlan, T. K., Sang, N., Druck, T., Veronese, M. L., Allen, S. L., Chiorazzi, N., Koff, A., Heubner, K., & Croce, C. M. (1995) · PubMed · Cited by 107
Platelet‐derived growth factor is mitogenic for O‐2Aadult progenitor cells
Wolswijk, G., Riddle, P. N., & Noble, M. (1991) · Glia · doi:10.1002/glia.440040509 · Cited by 105
MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells.
Wechsler, D. S., Shelly, C., Petroff, C. A., & Dang, C. V. (1997) · PubMed · Cited by 100
Lin, H., Bondy, M. L., Langford, L. A., Hess, K. R., Delclos, G. L., Wu, X., Chan, W., Pershouse, M. A., Yung, W. K. A., & Steck, P. A. (1998) · PubMed · Cited by 93
Edelhoff, S., Ayer, D. E., Zervos, A. S., Steingrı́msson, E., Jenkins, N. A., Copeland, N. G., Eisenman, R. N., Brent, R., & Distèche, C. M. (1994) · PubMed · Cited by 92
Pohl, U., Smith, J. S., Tachibana, I., Ueki, K., Lee, H. K., Ramaswamy, S., Wu, Q., Mohrenweiser, H. W., Jenkins, R. B., & Louis, D. N. (2000) · Genomics · doi:10.1006/geno.1999.6087 · Cited by 91
Self-citationDevelopmental changes in progenitor cell responsiveness to cytokines
Zhu, G., Mehler, M. F., Mabie, P. C., & Kessler, J. A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990415)56:2<131::aid-jnr3>3.0.co;2-i · Cited by 90
Scolding, N. J., Rayner, P. J., & Compston, D. A. S. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00548-x · Cited by 89
Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
von Deimling, A., Bender, B., Jahnke, R., Waha, A., Kraus, J., Albrecht, S., Wellenreuther, R., Faßbender, F., Nagel, J., & Menon, A. G. (1994) · PubMed · Cited by 88
Bilato, C., Pauly, R. R., Melillo, G., Monticone, R. E., Gorelick-Feldman, D. A., Gluzband, Y. A., Sollott, S. J., Ziman, B. D., Lakatta, E. G., & Crow, M. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118236 · Cited by 87
Landau, B., Kwaan, H. C., Verrusio, E., & Brem, S. S. (1994) · PubMed · Cited by 85
Yeh, H. J., Silos‐Santiago, I., Wang, Y. X., George, R. J., Snider, W. D., & Deuel, T. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1952 · Cited by 84
PTEN and inherited hamartoma-cancer syndromes
Eng, C., & Peacocke, M. (1998) · Nature Genetics · doi:10.1038/897 · Cited by 83
Tikoo, R., Osterhout, D. J., Casaccia‐Bonnefil, P., et al. (1998) · PubMed · Cited by 77
Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.
Gonzalez–Fernandez, F., Lopes, M. B. S., García-Fernández, J. M., Foster, F., Grip, W. J. D., Rosemberg, S., Newman, S. A., & VandenBerg, S. R. (1992) · PubMed Central · Cited by 71
Weickert, C. S., & Blum, M. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00026-a · Cited by 67
Increased proliferation of precursor cells in the adult rat brain after targeted lesioning
Weinstein, D. E., Burrola, P., & Kilpatrick, T. J. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00979-1 · Cited by 63
Tikoo, R., Osterhout, D. J., Casaccia‐Bonnefil, P., Seth, P. K., Koff, A., & Chao, M. V. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19980905)36:3<431::aid-neu10>3.0.co;2-e · Cited by 63
Secretion of cathepsin B by human gliomas in vitro
McCormick, D. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00420.x · Cited by 56
El‐Obeid, A., Bongcam‐Rudloff, E., Sörby, M., Östman, A., Nistér, M., & Westermark, B. (1997) · PubMed · Cited by 55
Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes
Demetrick, D. J., Zhang, H., & Beach, D. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133669 · Cited by 52
A Cell Cycle Alteration Precedes Apoptosis of Granule Cell Precursors in the weaver Mouse Cerebellum
Migheli, A., Piva, R., Casolino, S., Atzori, C., Dlouhy, S. R., & Ghetti, B. F. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65133-4 · Cited by 50
Facchiano, A., Marchis, F. D., Turchetti, E., Facchiano, F., Guglielmi, M. B., Denaro, A., Palumbo, R., Scoccianti, M., & Capogrossi, M. C. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2855 · Cited by 49
Landau, B., Brern, S., Verrusio, E., & Kwaan, H. C. (1994) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(94)90453-7 · Cited by 42
Molecular biology of central nervous system tumors
Rempel, S. A. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199805000-00002 · Cited by 36
Arap, W., Knudsen, E. S., Sewell, D. A., Sidransky, D., Wang, J. Y. J., Huang, H.-J. S., & Cavenee, W. K. (1997) · Oncogene · doi:10.1038/sj.onc.1201389 · Cited by 32
Self-citationWillis, A. I., Fuse, S., Wang, X. J., Chen, E., Tuszynski, G. P., Sumpio, B. E., & Gahtan, V. (2000) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(00)90106-x · Cited by 25
Neurogenesis and Gliogenesis in the Postischemic Brain
Liu, J., Bernabeu, R., Lu, A., & Sharp, F. R. (2000) · The Neuroscientist · doi:10.1177/107385840000600510 · Cited by 8
Research works printed but not linked: 25
- Al-Awqati, 1999, Terminal differentiation in epithelia: The Hensin pathway in intercalated cells., Semin. Nephrol., 19, 415
- Biernat, 1995, Identical mutations of the p53 tumor supressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells., J. Neuropathol. Exp. Neurol., 54, 651, 10.1097/00005072-199509000-00006 · doi:10.1097/00005072-199509000-00006
- Bouchard, 1960, Radiation therapy in the management of neoplasms of the central nervous system, with a special note in regard to children: Twenty years experience., Am. J. Roentgenol., 84, 610
- 10.1016/0006-8993(85)90802-9 · doi:10.1016/0006-8993(85)90802-9
- 10.1002/(SICI)1097-4547(19980901)53:5<521::AID-JNR2>3.0.CO;2-B · doi:10.1002/(sici)1097-4547(19980901)53:5<521::aid-jnr2>3.0.co;2-b
- 10.1006/exnr.2000.7482 · doi:10.1006/exnr.2000.7482
- 10.1046/j.1471-4159.2000.0741393.x · doi:10.1046/j.1471-4159.2000.0741393.x
- Heldin, 1996, Protein tyrosine kinase receptors., Cancer Surveys, 27, 7
- 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1 · doi:10.1002/(sici)1098-2264(199805)22:1<9::aid-gcc2>3.0.co;2-1
- James, 1991, Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors., Cancer Res., 51, 1684
- McKeever, 1991, Patterns of antigenic expression of human glioma cells., Crit. Rev. Neurobiol., 6, 119
- 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9 · doi:10.1002/(sici)1098-1136(199701)19:1<85::aid-glia9>3.0.co;2-9
- Mishima, K., Nagane, M., Lin, H., Cavenee, W., and Huang, H.J.S. 1999. Expression of a specific mutant epidermal growth factor receptor mediates glioma cell invasion in vivo. Proc. Am. Assoc. Cancer Res.: 519..
- 10.1007/BF00713052 · doi:10.1007/bf00713052
- Mueller, 2001, Clonal analysis in glioblastoma with epithelial differentation., Brain Pathol., 11, 39, 10.1111/j.1750-3639.2001.tb00379.x · doi:10.1111/j.1750-3639.2001.tb00379.x
- Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes., Oncogene, 11, 635
- Rubio, 1994, Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas., Cancer Res., 54, 45
- 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U · doi:10.1002/(sici)1521-1878(199810)20:10<808::aid-bies6>3.0.co;2-u
- 10.1002/(SICI)1098-1136(199903)26:1<22::AID-GLIA3>3.0.CO;2-M · doi:10.1002/(sici)1098-1136(199903)26:1<22::aid-glia3>3.0.co;2-m
- Small R.K. (1992) Glial cell lineages in development and disease. in Disease of the nervous system: Clinical Neurobiology, eds Ashurry A.K. McKhann G.M. McDonald W.I. (W.B. Saunders Company, Philadelphia), pp 72–86.
- Smith, J.S., Tachibana, I., Pohl, U., Lee, H.K., Thanarajasigam, U., Portier, B.P., Ueki, K., Ramaswamy, S., Billings, S.J., Mohrenweiser, H.W., et al. 2000. A transcript map of the chromosome 19 q-arm tumor supressor region. Genomics , in press.. · doi:10.1006/geno.1999.6101
- Takito, 1999, Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas., Am. J. Physiol., 277, F277
- Tsai, 2000, Cell contact regulates fate choice by cortical stem cells., J. Neurosci., 20, 3725, 10.1523/JNEUROSCI.20-10-03725.2000 · doi:10.1523/jneurosci.20-10-03725.2000
- 10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(20000201)85:3<398::aid-ijc17>3.0.co;2-l
- 10.1006/geno.1995.9972 · doi:10.1006/geno.1995.9972
Cited by
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., & Sımjee, S. U. (2017) · PubMed · doi:10.22034/apjcp.2017.18.1.3 · Cited by 1,231
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Metadata
- Authors
- Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-06-01
- Volume
- 15
- Issue
- 11
- Pages
- 1311-1333
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2114998237
- Cited by
- 1,229
- References
- 195
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.